home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Using Biomarkers To Predict Alzheimer's Disease

  November, 1 2007 1:38
your information resource in human molecular genetics
A plasma biomarker could be used to predict which patients with mild cognitive impairment will go on to develop Alzheimer's disease, suggests a study in the November 2007 issue of Nature Medicine.

Tony Wyss-Coray and colleagues find 18 plasma signalling proteins that can correctly classify patients with Alzheimer's compared with patients with other types of dementia or compared with controls. These same biomarkers can then predict which patients with mild cognitive impairment will progress to develop dementia characteristic of Alzheimer's disease.

This biomarker panel could be used to target early treatment only to patients that are most likely to benefit from it -- patients with mild cognitive impairment that are destined to develop full-blown Alzheimer's disease.

Author contact:

Tony Wyss-Coray (Stanford University, CA, USA)
E-mail: twc@stanford.edu

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.